Bioelectronics Corp (BIEL)

[alexander77]

Q report was rather satisfying with almost zero increase in O/S.
1. company is undervalued... investors were afraid that O/S did increase big time through dilution, but instead the decrease in PPS was due to shorting and impatient shareholders

2. because the 90D average volume has been more than doubled today, I believe there is more upto than only an upwards pps correction. Possibilities:

-- FDA clearance
-- uplisting
-- institutional investments
-- more partnerships and distibutors
-- (buyout)

PS remember this analyst saying almost 1 year ago, that pps should be around 0.30 - 0.50 when the products were FDA cleared?